Pharming Group N.V. ADS, each representing 10 ordinary shares Stock Prediction
AI-powered sentiment analysis and prediction trends for PHAR, updated each market day.
PHAR AI Sentiment
AI sees no strong directional signal for Pharming Group N.V. ADS, each representing 10 ordinary shares stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Pharming Group N.V. ADS, each representing 10 ordinary shares
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Exchange
Market Cap
$1,175,203,827
Cap Tier
Employees
409
Listed Since
Dec. 23, 2020
Website
PHAR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PHAR Volatility
Pharming Group N.V. ADS, each representing 10 ordinary shares has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
